Double-blind trial of four hypotensive drugs (methyldopa and three sympatholytic agents).
Data up to Jan 2025
Total Citations Per Year
Abstract
References (20)
Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanine
1960 • 254 citations
Norepinephrine Depletion as a Possible Mechanism of Action of Guanethidine a New Hypotensive Agent
1960 • 155 citations
Clinical and Chemical Studies with α -Methyl-Dopa in Patients with Hypertension
1962 • 146 citations
A NEW, POTENT ANTIHYPERTENSIVE DRUG
1959 • 116 citations
[2-(Octahydro-1-azocinyl)-ethyl]-guanidine sulfate (CIBA 5864-SU), a new synthetic antihypertensive agent
1959 • 92 citations
METHYLDOPA IN THE TREATMENT OF HYPERTENSION
1962 • 67 citations
BRETYLIUM TOSYLATE IN THE TREATMENT OF HYPERTENSION
1960 • 65 citations
Treatment of hypertension with methyldopa.
1966 • 58 citations
The Relative Efficacy of Guanethidine, Methyldopa and Pargyline as Antihypertensive Agents
1965 • 56 citations
Combined Clinical and Metabolic Study of the Effects of Alpha-Methyldopa on Hypertensive Patients
1966 • 48 citations
Guanethidine in the Treatment of Hypertension
1963 • 29 citations
Another Hypotensive Agent--Methyldopa
1962 • 25 citations
Clinical Trial of 2-Guanidinomethyl (1,4) Benzodioxan (Compound 1003)
1964 • 19 citations
Clinical Trial and Pharmacological Study of Compound 1029 ("Vatensol")
1964 • 17 citations
PHARMACOLOGY OF THE ANTIHYPERTENSIVE GUANOXAN
1965 • 16 citations
Methyldopa in Treatment of Hypertension Due to Chronic Renal Disease
1964 • 16 citations
COMBINED ACTION OF METHYLDOPA AND BETHANIDINE
1966 • 8 citations
Side-effects of guanoxan.
1966 • 7 citations
GUANOXAN IN HYPERTENSION
1964 • 5 citations
[Guanethidine (Ismelin) in the treatment of arterial hypertension].
1961 • 1 citations